Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  COMPASS Pathways plc    CMPS

COMPASS PATHWAYS PLC

(CMPS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/24/2020 11/25/2020 11/27/2020 11/30/2020 12/01/2020 Date
37.3(c) 40.83(c) 47.45(c) 49.84(c) 44.61(c) Last
385 522 931 861 821 217 871 032 561 670 Volume
+4.39% +9.46% +16.21% +5.04% -10.49% Change
More quotes
Financials (USD)
Sales 2020 - - -
Net income 2020 -54,5 M - -
Net cash position 2020 167 M - -
P/E ratio 2020 -19,7x
Yield 2020 -
Sales 2021 - - -
Net income 2021 -64,5 M - -
Net cash position 2021 227 M - -
P/E ratio 2021 -26,0x
Yield 2021 -
Capitalization 1 603 M 1 603 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees -
Free-Float 15,1%
More Financials
Company
COMPASS Pathways PLC is a mental health care company. The Company is focused on developing treatments for people suffering with mental health challenges. It is initially focused on treatment-resistant depression (TRD). It is developing COMP360, a polymorphic crystalline formulation of psilocybin. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from specially trained... 
More about the company
All news about COMPASS PATHWAYS PLC
11/12COMPASS PATHWAYS : announces financial results for third quarter 2020
AQ
11/12COMPASS PATHWAYS : announces financial results for third quarter 2020
AQ
11/12COMPASS Pathways plc announces financial results for third quarter 2020
GL
11/09COMPASS PATHWAYS : joins the Psychiatry Consortium in a collaboration to acceler..
AQ
11/09COMPASS PATHWAYS : joins the Psychiatry Consortium in a collaboration to acceler..
AQ
11/09COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accel..
GL
10/26COMPASS PATHWAYS : to ring Nasdaq Stock Exchange opening bell in celebration of ..
AQ
10/26COMPASS PATHWAYS : to ring Nasdaq Stock Exchange opening bell in celebration of ..
AQ
10/26COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebratio..
GL
09/22COMPASS Pathways announces closing of initial public offering of American Dep..
GL
09/17COMPASS Pathways announces pricing of upsized initial public offering
GL
More news
News in other languages on COMPASS PATHWAYS PLC

- No features available -

More news
Chart COMPASS PATHWAYS PLC
Duration : Period :
COMPASS Pathways plc Technical Analysis Chart | CMPS | US20451W1018 | MarketScreener
Technical analysis trends COMPASS PATHWAYS PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 65,00 $
Last Close Price 44,61 $
Spread / Highest target 79,3%
Spread / Average Target 45,7%
Spread / Lowest Target 12,1%
EPS Revisions
Managers
NameTitle
George Jay Goldsmith Chief Executive Officer & Director
Lars Christian Wilde President & Chief Business Officer
Piers John Morgan Chief Financial Officer
Ekaterina Malievskaia Director & Chief Innovation Officer
Annalisa Mary Jenkins Director
Sector and Competitors
1st jan.Capitalization (M$)
COMPASS PATHWAYS PLC0.00%1 603
MODERNA, INC.620.91%60 441
LONZA GROUP AG61.27%46 692
CELLTRION, INC.87.85%41 055
IQVIA HOLDINGS INC.9.37%32 400
SEAGEN INC.55.27%30 708